{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:34:53Z","timestamp":1791340493518,"version":"4.3.1"},"reference-count":78,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,10,6]]},"DOI":"10.18632\/oncotarget.4999","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T21:54:23Z","timestamp":1443563663000},"page":"30149-30164","source":"Crossref","is-referenced-by-count":47,"title":["Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma"],"prefix":"10.18632","volume":"6","author":[{"given":"G\u00e9raldine","family":"Mitou","sequence":"first","affiliation":[{"name":"Inserm, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"CNRS, ERL5294 CRCT, F-31000 Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Frentzel","sequence":"additional","affiliation":[{"name":"Inserm, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"CNRS, ERL5294 CRCT, F-31000 Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Desquesnes","sequence":"additional","affiliation":[{"name":"Phenotyping Service, INSERM-US006 ANEXPLO\/CREFRE, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Le Gonidec","sequence":"additional","affiliation":[{"name":"Phenotyping Service, INSERM-US006 ANEXPLO\/CREFRE, Toulouse, France"},{"name":"Universit\u00e9 Toulouse III - Paul Sabatier, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"AlSaati","sequence":"additional","affiliation":[{"name":"INSERM\/UPS - US006\/CREFRE, Service d'Histopathologie, CHU Purpan, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Beau","sequence":"additional","affiliation":[{"name":"INSERM UMRS 1185; Facult\u00e9 de M\u00e9decine Paris Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lamant","sequence":"additional","affiliation":[{"name":"Inserm, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"CNRS, ERL5294 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III - Paul Sabatier, Toulouse, France"},{"name":"Department of Pathology, IUCT, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Meggetto","sequence":"additional","affiliation":[{"name":"Inserm, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"CNRS, ERL5294 CRCT, F-31000 Toulouse, France"},{"name":"European Research Initiative on ALK-related malignancies (ERIA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Espinos","sequence":"additional","affiliation":[{"name":"Inserm, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"CNRS, ERL5294 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III - Paul Sabatier, Toulouse, France"},{"name":"European Research Initiative on ALK-related malignancies (ERIA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Codogno","sequence":"additional","affiliation":[{"name":"Institut Necker Enfants-Malades, INSERM U1151-CNRS UMR 8253, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brousset","sequence":"additional","affiliation":[{"name":"Inserm, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"CNRS, ERL5294 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III - Paul Sabatier, Toulouse, France"},{"name":"Department of Pathology, IUCT, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Giuriato","sequence":"additional","affiliation":[{"name":"Inserm, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"Universit\u00e9 Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France"},{"name":"CNRS, ERL5294 CRCT, F-31000 Toulouse, France"},{"name":"European Research Initiative on ALK-related malignancies (ERIA)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Jaffe","year":"2011","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.annpat.2008.09.002","article-title":"The WHO lymphoma classification","volume":"28","author":"Delsol","year":"2008","journal-title":"Ann Pathol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Look","year":"1994","journal-title":"Science (80-.)"},{"key":"4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Inghirami","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2217\/fon.13.184","article-title":"ALK-positive cancer: still a growing entity","volume":"10","author":"Biernat","year":"2014","journal-title":"Futur. Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3580","article-title":"Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology","volume":"13","author":"Palmer","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1182\/blood-2008-06-163386","article-title":"Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma\/leukemia","volume":"115","author":"Meggetto","year":"2010","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.leu.2403797","article-title":"What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?","volume":"19","author":"Alexander","year":"2005","journal-title":"Leukemia"},{"key":"9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2741\/s437","article-title":"Twenty years of modelling NPM-ALK-induced lymphomagenesis","volume":"7","author":"Turner","year":"2015","journal-title":"Front Biosci (Schol Ed)"},{"key":"10","first-page":"41","article-title":"ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma","volume":"2","author":"Inghirami","year":"2012","journal-title":"Front Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-11-0776","article-title":"CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers","volume":"11","author":"Ator","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"12","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.18632\/oncotarget.2170","article-title":"The ALK inhibitor ASP3026 eradicates NPM-ALK(+) T-cell anaplastic large-cell lymphomaand in a systemic xenograft lymphoma model","volume":"5","author":"Amin","year":"2014","journal-title":"Oncotarget"},{"key":"13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1517\/14728222.2012.719498","article-title":"Anaplastic lymphoma kinase as a therapeutic target","volume":"16","author":"Lamant","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"14","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/labinvest.3700348","article-title":"Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3","volume":"85","author":"Wasik","year":"2005","journal-title":"Lab Invest"},{"key":"15","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1158\/1535-7163.MCT-07-0365","article-title":"Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma","volume":"6","author":"Los","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"16","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Wilner","year":"2010","journal-title":"N Engl J Med"},{"key":"17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(13)70095-0","article-title":"Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study","volume":"14","author":"Adamson","year":"2013","journal-title":"Lancet Oncol"},{"key":"18","first-page":"djt378","article-title":"Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients","volume":"106","author":"King","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"19","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa1007478","article-title":"EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors","volume":"363","author":"Mitsudomi","year":"2010","journal-title":"N Engl J Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/1078-0432.CCR-11-2906","article-title":"Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer","volume":"18","author":"Camidge","year":"2012","journal-title":"Clin Cancer Res"},{"key":"21","first-page":"120ra17","article-title":"Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers","volume":"4","author":"Crosby","year":"2012","journal-title":"Sci Transl Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1158\/0008-5472.CAN-11-1340","article-title":"A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors","volume":"71","author":"Ercan","year":"2011","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/nm.2966","article-title":"PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas","volume":"18","author":"Simonitsch-Klupp","year":"2012","journal-title":"Nat Med"},{"key":"24","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1517\/13543784.2012.717930","article-title":"The battle against ALK resistance: successes and setbacks","volume":"21","author":"Chiarle","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/10428194.2011.614706","article-title":"Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma","volume":"53","author":"Cashen","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"26","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1200\/JCO.2010.30.8338","article-title":"Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer","volume":"28","author":"Fritz","year":"2010","journal-title":"J Clin Oncol"},{"key":"27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Hunter","year":"2009","journal-title":"J Clin Invest"},{"key":"28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/10428194.2010.546913","article-title":"Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors","volume":"52","author":"Salomoni","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"29","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1073\/pnas.1000248107","article-title":"Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST)","volume":"107","author":"Debnath","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1349-7006.2008.00932.x","article-title":"Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors","volume":"99","author":"Hatake","year":"2008","journal-title":"Cancer Sci"},{"key":"31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion: molecular mechanisms and biological functions of autophagy","volume":"6","author":"Klionsky","year":"2004","journal-title":"Dev Cell"},{"key":"32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-cellbio-092910-154005","article-title":"The role of Atg proteins in autophagosome formation","volume":"27","author":"Ohsumi","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1016\/j.cub.2011.11.034","article-title":"Mechanisms of autophagosome biogenesis","volume":"22","author":"Elazar","year":"2012","journal-title":"Curr Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrm3696","article-title":"The autophagosome: origins unknown, biogenesis complex","volume":"14","author":"Tooze","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.biocel.2011.01.006","article-title":"Autophagosomes and human diseases","volume":"43","author":"Codogno","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1158\/1078-0432.CCR-07-5023","article-title":"The double-edged sword of autophagy modulation in cancer","volume":"15","author":"DiPaola","year":"2009","journal-title":"Clin Cancer Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1017\/S1462399409001306","article-title":"The role of autophagy in tumour development and cancer therapy","volume":"11","author":"Ryan","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semcancer.2013.06.007","article-title":"Autophagy regulation and its role in cancer","volume":"23","author":"Codogno","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"39","first-page":"856","article-title":"Autophagy in malignant transformation and cancer progression","author":"Levine","year":"2015","journal-title":"EMBO, J"},{"key":"40","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1101\/gad.1545107","article-title":"Autophagy suppresses tumor progression by limiting chromosomal instability","volume":"21","author":"White","year":"2007","journal-title":"Genes Dev"},{"key":"41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/auto.3269","article-title":"Role of autophagy in cancer: management of metabolic stress","volume":"3","author":"White","year":"2007","journal-title":"Autophagy"},{"key":"42","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2010-01-261040","article-title":"Autophagy contributes to therapy-induced degradation of the PML\/RARA oncoprotein","volume":"116","author":"Simonsen","year":"2010","journal-title":"Blood"},{"key":"43","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2012-01-402578","article-title":"Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide","volume":"120","author":"Platanias","year":"2012","journal-title":"Blood"},{"key":"44","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.4161\/auto.5.8.10122","article-title":"Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies","volume":"5","author":"Panaretakis","year":"2009","journal-title":"Autophagy"},{"key":"45","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1158\/0008-5472.CAN-09-3537","article-title":"Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62\/SQSTM1 expression and AMPK activation","volume":"70","author":"Auberger","year":"2010","journal-title":"Cancer Res"},{"key":"46","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI37948","article-title":"Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells","volume":"119","author":"Piacentini","year":"2009","journal-title":"J Clin Invest"},{"key":"47","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Menger","year":"2011","journal-title":"Science"},{"key":"48","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ijc.24402","article-title":"The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells","volume":"125","author":"Brodie","year":"2009","journal-title":"Int J Cancer"},{"key":"49","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2013-05-500629","article-title":"Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells","volume":"122","author":"Simonsen","year":"2013","journal-title":"Blood"},{"key":"50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","article-title":"Deconvoluting the context-dependent role for autophagy in cancer","volume":"12","author":"White","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pharmthera.2011.03.009","article-title":"Targeting autophagy during cancer therapy to improve clinical outcomes","volume":"131","author":"Thorburn","year":"2011","journal-title":"Pharmacol Ther"},{"key":"52","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.18632\/oncotarget.384","article-title":"Targeting autophagy addiction in cancer","volume":"2","author":"Kimmelman","year":"2011","journal-title":"Oncotarget"},{"key":"53","first-page":"439","article-title":"A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles","volume":"61","author":"Yahalom","year":"2001","journal-title":"Cancer Res"},{"key":"54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/auto.1.1.1270","article-title":"Maturation of autophagic vacuoles in Mammalian cells","volume":"1","author":"Eskelinen","year":"2005","journal-title":"Autophagy"},{"key":"55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4161\/auto.20353","article-title":"Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens","volume":"8","author":"Zitvogel","year":"2012","journal-title":"Autophagy"},{"key":"56","first-page":"1","article-title":"An overview of the molecular mechanism of autophagy","volume":"335","author":"Klionsky","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4161\/auto.1.2.1697","article-title":"Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy","volume":"1","author":"Kominami","year":"2005","journal-title":"Autophagy"},{"key":"58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Levine","year":"2010","journal-title":"Cell"},{"key":"59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Talalay","year":"1984","journal-title":"Adv Enzym. Regul"},{"key":"60","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"61","doi-asserted-by":"crossref","first-page":"10850","DOI":"10.1074\/jbc.M109.080796","article-title":"Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase","volume":"285","author":"Shen","year":"2010","journal-title":"J. Biol. Chem"},{"key":"62","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/auto.8.2.18554","article-title":"Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy","volume":"8","author":"Thorburn","year":"2012","journal-title":"Autophagy"},{"key":"63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ccr.2014.06.025","article-title":"Tumor vessel normalization by chloroquine independent of autophagy","volume":"26","author":"Garmyn","year":"2014","journal-title":"Cancer Cell"},{"key":"64","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/cdd.2010.170","article-title":"Stimulation of the midkine\/ALK axis renders glioma cells resistant to cannabinoid antitumoral action","volume":"18","author":"Guzman","year":"2011","journal-title":"Cell Death Differ"},{"key":"65","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4161\/cbt.28162","article-title":"Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer","volume":"15","author":"Ren","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"66","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1158\/0008-5472.CAN-10-3879","article-title":"Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors","volume":"71","author":"Pao","year":"2011","journal-title":"Cancer Res"},{"key":"67","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1158\/2159-8290.CD-12-0440","article-title":"Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer","volume":"3","author":"He","year":"2013","journal-title":"Cancer Discov"},{"key":"68","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4161\/auto.27719","article-title":"When cytoprotective autophagy isn't\u2026 and even when it is","volume":"10","author":"Gewirtz","year":"2014","journal-title":"Autophagy"},{"key":"69","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/PPO.0b013e31826aef4a","article-title":"Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma","volume":"18","author":"Bartlett","year":"2012","journal-title":"Cancer J"},{"key":"70","first-page":"775","article-title":"Crizotinib in anaplastic large-cell lymphoma","volume":"364","author":"Pogliani","year":"2010","journal-title":"N Engl J Med"},{"key":"71","first-page":"3917","article-title":"The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells","volume":"118","author":"Bast","year":"2008","journal-title":"J Clin Invest"},{"key":"72","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.4161\/auto.6.8.13430","article-title":"Therapeutic implications of autophagy-mediated cell survival in gastrointestinal stromal tumor after treatment with imatinib mesylate","volume":"6","author":"Debnath","year":"2010","journal-title":"Autophagy"},{"key":"73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4614-1445-2_5","article-title":"Regulation of tumor cell dormancy by tissue microenvironments and autophagy","volume":"734","author":"Aguirre-Ghiso","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"74","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"mTOR regulation of autophagy","volume":"584","author":"Kim","year":"2010","journal-title":"FEBS Lett"},{"key":"75","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1158\/0008-5472.CAN-05-3018","article-title":"Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma","volume":"66","author":"Rassidakis","year":"2006","journal-title":"Cancer Res"},{"key":"76","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/sj.onc.1210346","article-title":"Oncogenic tyrosine kinase NPM\/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway","volume":"26","author":"Wasik","year":"2007","journal-title":"Oncogene"},{"key":"77","article-title":"Outcome of early clinical trials of the combination of hydroxychloroquine with chemotherapy in cancer","volume":"10","author":"Gewirtz","year":"2014","journal-title":"Autophagy"},{"key":"78","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djr168","article-title":"Inducing indigestion: companies embrace autophagy inhibitors","volume":"103","author":"Garber","year":"2011","journal-title":"J Natl Cancer Inst"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:21:08Z","timestamp":1599610868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":78,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2015,10,6]]}},"alternative-id":["4999","26338968"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.4999","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,17]]}}}